17-58005875-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_006924.5(SRSF1):c.478G>A(p.Val160Met) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
SRSF1
NM_006924.5 missense
NM_006924.5 missense
Scores
5
11
3
Clinical Significance
Conservation
PhyloP100: 5.83
Genes affected
SRSF1 (HGNC:10780): (serine and arginine rich splicing factor 1) This gene encodes a member of the arginine/serine-rich splicing factor protein family. The encoded protein can either activate or repress splicing, depending on its phosphorylation state and its interaction partners. Multiple transcript variants have been found for this gene. There is a pseudogene of this gene on chromosome 13. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM1
In a chain Serine/arginine-rich splicing factor 1 (size 246) in uniprot entity SRSF1_HUMAN there are 7 pathogenic changes around while only 0 benign (100%) in NM_006924.5
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-58005875-C-T is Pathogenic according to our data. Variant chr17-58005875-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2429781.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-58005875-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRSF1 | NM_006924.5 | c.478G>A | p.Val160Met | missense_variant | 3/4 | ENST00000258962.5 | NP_008855.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRSF1 | ENST00000258962.5 | c.478G>A | p.Val160Met | missense_variant | 3/4 | 1 | NM_006924.5 | ENSP00000258962.4 | ||
ENSG00000266086 | ENST00000578794.2 | n.478G>A | non_coding_transcript_exon_variant | 3/6 | 3 | ENSP00000463235.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | Mar 19, 2024 | This sequence variant is a single nucleotide substitution (G>A) at position 478 of the coding sequence of the SRSF1 gene that results in a valine to methionine amino acid change at residue 160 of the serine and arginine rich splicing factor 1 protein. The 160 residue falls in the RRM 2 domain (UniProt). This is a previously reported variant (ClinVar 2429781) that has been observed in individuals affected by a neurodevelopmental disorder (PMID: 37071997, 35468861). This variant is absent from the gnomAD population database v4.0.0 (0 of approximately 780,000 alleles). Multiple bioinformatic tools predict that this amino acid change would be damaging, and the Val160 residue at this position is highly conserved across the vertebrate species examined. When introduced into Drosophilia, this variant disrupted serine and arginine rich splicing factor 1 protein's function (PMID: 37071997). Based upon the evidence, we consider this variant to be likely pathogenic. ACMG Criteria: PM2, PP2, PP3 - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 29, 2023 | - - |
Intellectual disability;C4022738:Neurodevelopmental delay Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Feb 15, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
H;.;H
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D
REVEL
Uncertain
Sift
Uncertain
.;.;D
Sift4G
Uncertain
T;D;D
Polyphen
1.0
.;.;D
Vest4
MutPred
Loss of methylation at K165 (P = 0.1553);Loss of methylation at K165 (P = 0.1553);Loss of methylation at K165 (P = 0.1553);
MVP
MPC
3.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.